
Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

